Amylin Pharmaceuticals to Present At Roth Capital Partners Growth Stock Conference
February 12 2004 - 7:30AM
PR Newswire (US)
Amylin Pharmaceuticals to Present At Roth Capital Partners Growth
Stock Conference SAN DIEGO, Feb. 12 /PRNewswire-FirstCall/ --
Amylin Pharmaceuticals, Inc. will be presenting at the Roth Capital
Partners Growth Stock Conference on Tuesday, February 17, 2004 at
9:00 a.m. Pacific Time at The St. Regis Monarch Beach Resort in
Dana Point, CA. Mark G. Foletta, Vice President, Finance and Chief
Financial Officer of Amylin Pharmaceuticals, will be providing a
corporate overview. The presentation willbe webcast live by Roth
Capital Partners, and a recording will be made available
approximately one hour following the event. The webcast and
recording will be accessible through Amylin's corporate website,
http://www.amylin.com/ . To access the live webcast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
Amylin Pharmaceuticals is committed to improving the lives of
people with diabetes and other metabolicdiseases through the
discovery, development and commercialization of innovative,
cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Mark G. Foletta, Vice President of Finance and Chief
Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200
Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024